| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1985) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | V08AB02 |
| UNII: | 4419T9MX03 |
Structure
| InChI Key | NTHXOOBQLCIOLC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C19H26I3N3O9 |
| Molecular Weight | 821.14 |
| AlogP | -1.63 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 8.0 |
| Number of Rotational Bond | 12.0 |
| Polar Surface Area | 199.89 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 34.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Diagnostic agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myocardial Ischemia | 3 | D017202 | ClinicalTrials |
| Kidney Diseases | 2 | D007674 | ClinicalTrials |
| Acute Kidney Injury | 2 | D058186 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Fabry Disease | 1 | D000795 | ClinicalTrials |
| HIV Infections | 1 | D015658 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Renal Insufficiency | 1 | D051437 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Related Entries
MCS
Side Effects from Label
Side Effects (PT)
| Side effects | Relative Frequency (%) | Labels | |
|---|---|---|---|
| General disorders and administration site conditions Pain | 26.0 | ||
| General disorders and administration site conditions Swelling | 22.0 |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 66108-95-0 |
| ChEBI | 31709 |
| ChEMBL | CHEMBL1200455 |
| DrugBank | DB01362 |
| DrugCentral | 1461 |
| EPA CompTox | DTXSID6023157 |
| FDA SRS | 4419T9MX03 |
| Human Metabolome Database | HMDB15449 |
| PharmGKB | PA450061 |
| PubChem | 3730 |
| SureChEMBL | SCHEMBL26501 |
CONTENTS